投资者提问：2026年1月份已经过去，美国合作伙伴是否已申请2026年第一...

Core Viewpoint - The company, Yifan Pharmaceutical, is in the early stages of market introduction for its product, Yilishu, in the U.S. and is not yet experiencing significant sales volume [1] Group 1 - The procurement volume of Yilishu by its U.S. partner is determined by agreements and orders, which may not directly correlate with actual end-user sales [1] - Yilishu has been on the U.S. market for less than a year and is still in the initial ramp-up phase of its introduction [1]